leisure time -WSS

leisure time

author：leisure time 2025-09-27 10:06:19 - browse：1733

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Ambulance rides for just $100? Advisers want major billing fixes

hotspot

WSS

Juul documents reveal insider tactics on political lobbying

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Extreme heat events are a public health emergency

The new shift in health care is toward less care

Just how powerful is the placebo effect?

Here’s what’s in the FDA plan to include pregnant women in clinical trials

leisure time

leisure time

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Study: New antibiotic targets gonorrhea as well as last existing drug

The cancer drug shortage isn’t new — and neither are the solutions

Diversify hospital leadership teams to protect BIPOC patient health

At least 13 dead in Texas as scorching temps continue

Medicare will require more price transparency from hospitals

Drug repurposing or repositioning? The language matters

FDA approves Recor Medical high blood pressure device

Medicare proposal to cover medical devices draws a mixed reaction

Sanofi CEO defends move to abandon profit guidance, boost research

explore

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Congress must protect the remaining independent doctors

A clever new way to fix Medicaid and graduate medical education

UCSF medical school apologizes for unethical prisoner experiments

Too many hospitalized Covid

Wikipedia

hotspot

knowledge

Wikipedia